Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avalon GloboCare (ALBT) Gains from Sales and Divestitures (2017 - 2025)

Historic Gains from Sales and Divestitures for Avalon GloboCare (ALBT) over the last 8 years, with Q3 2025 value amounting to $80000.0.

  • Avalon GloboCare's Gains from Sales and Divestitures changed N/A to $80000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $80000.0, marking a year-over-year change of. This contributed to the annual value of $86583.0 for FY2022, which is 97.14% up from last year.
  • As of Q3 2025, Avalon GloboCare's Gains from Sales and Divestitures stood at $80000.0.
  • Avalon GloboCare's Gains from Sales and Divestitures' 5-year high stood at $651668.0 during Q3 2021, with a 5-year trough of $19137.0 in Q1 2023.
  • In the last 4 years, Avalon GloboCare's Gains from Sales and Divestitures had a median value of $212501.0 in 2022 and averaged $260482.3.
  • In the last 5 years, Avalon GloboCare's Gains from Sales and Divestitures crashed by 9572.62% in 2021 and then surged by 97.14% in 2022.
  • Over the past 4 years, Avalon GloboCare's Gains from Sales and Divestitures (Quarter) stood at $85750.0 in 2021, then increased by 0.97% to $86583.0 in 2022, then soared by 107.89% to $179998.0 in 2023, then plummeted by 55.56% to $80000.0 in 2025.
  • Its Gains from Sales and Divestitures was $80000.0 in Q3 2025, compared to $80000.0 in Q2 2025 and $179998.0 in Q3 2023.